Home/Sponsorship/Meet our Exhibitors


The African Organisation for Research and Training in Cancer (AORTIC) is an Africa-based organisation with members throughout Africa and the international cancer community. Our objectives are to support, integrate, and facilitate evidence-based interventions and innovative programmes towards the prevention and control of cancer in Africa.

The mission of the American Association for Cancer Research (AACR) is to prevent and cure cancer through: Research, Education, Communication, Collaboration, Science Policy and Advocacy, and Funding for Cancer Research.
Through its programs and services, the AACR fosters research in cancer and related biomedical science; accelerates the dissemination of new research findings among scientists and others dedicated to the conquest of cancer; promotes science education and training; and advances the understanding of cancer etiology, prevention, diagnosis, and treatment throughout the world.
Visit www.aacr.org for further information.

The ABC Global Alliance established in 2016 as an initiative of the European School of Oncology and now registered as a non-profit association in Portugal, is a multi-stakeholder platform for all those interested in collaborating on common projects relating to advanced breast cancer with the aim to improve and extend the lives of women and men living with ABC in all countries worldwide and to fight for a cure.
Visit www.abcglobalalliance.org for further information.

The American Society of Clinical Oncology and the Association for Clinical Oncology (collectively, ASCO) are multidisciplinary, global oncology organizations with nearly 45,000 members in over 150 countries. Through research, education, and promotion of the highest-quality, equitable patient care, members work to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. Our resources support oncology professionals at every stage of their career and across all patient care roles. Membership is free for all oncology trainees and students and is discounted for oncologists who practice in low- and middle- income countries.
Visit www.asco.org for further information.

Aligned with the World Health Organization’s (WHO) Global Strategy to accelerate the elimination of cervical cancer. the SUCCESS project – Scale Up Cervical Cancer Elimination with Secondary prevention Strategy – aims at screening 185,000 women, 40% of whom are living with HIV, in Burkina Faso, Côte d’Ivoire, Guatemala and the Philippines.
These four low- and middle-income countries are representative of resource-limited regions where more than 90% of the women who die from cervical cancer today are found. Moreover, women living with HIV are six times as likely to develop cervical cancer compared to women who are HIV negative.
SUCCESS, through its various activities, focuses on secondary prevention by introducing and expanding HPV screening within the screening and treatment of precancerous lesions. SUCCESS aims to build capacity in partner countries to improve coverage of cervical cancer control services by integrating secondary prevention services into both HIV services and reproductive health services. The project also engages in regional outreach with up to 20 countries through activities focusing on capacity building and health financing.
Funded by Unitaid, SUCCESS is implemented by Expertise France, with consortium partners including Jhpiego and the Union for International Cancer Control (UICC) and technical support partners including National Cancer Institutes of Brazil, France, Japan and USA.

Varian is the world’s leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Visit www.varian.com for more information.